EXACT SCIENCES CORP (EXAS) Gains from Investment Securities (2017 - 2025)

Exact Sciences (EXAS) has reported Gains from Investment Securities for 9 consecutive years, with $4.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Investment Securities rose 580.88% year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $26.8 million (up 901.17% YoY), while the FY2025 annual figure was $26.8 million, up 901.14% from the prior year.
• Gains from Investment Securities retreated to $4.9 million in Q4 2025 per EXAS's latest filing, from $8.7 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $36.9 million in Q4 2021 and bottomed at -$66.6 million in Q4 2022.
• Historically, Gains from Investment Securities has averaged -$5.6 million across 5 years, with a median of -$676000.0 in 2021.
• Annual changes were most pronounced in 2021 — Gains from Investment Securities soared 2587.18% — and 2022, when it slumped 8351.18%.
• Exact Sciences' Gains from Investment Securities stood at $36.9 million in 2021, then plunged by 280.73% to -$66.6 million in 2022, then jumped by 92.5% to -$5.0 million in 2023, then soared by 79.57% to -$1.0 million in 2024, then soared by 580.88% to $4.9 million in 2025.
• Business Quant data shows EXAS's Gains from Investment Securities at $4.9 million in Q4 2025, $8.7 million in Q3 2025, and $4.9 million in Q2 2025.